facebook
twitter
Login
Register
Medical Dialogues
Speciality Dialogues
Education Dialogues
Medical Jobs
Medical Matrimony
MD Brand Connect
News
Financial Results
Hospitals & Diagnostics
IT / Health Venture
Implants / Devices
Insurance
Key Movement
Pharmaceuticals
Policy
Technology
pharma-news
blog
Login
Register
Select Your Interest
Medical Dialogues
Speciality Dialogues
Education Dialogues
Medical Jobs
Medical Matrimony
Login
Register
Home
News
Financial Results
Hospitals & Diagnostics
IT / Health Venture
Implants / Devices
Insurance
Key Movement
Pharmaceuticals
Policy
Technology
pharma-news
blog
Home
News
Fortis board decides to consider only Binding Offers, Faces Backlash
Cognizant completes acquisition of Bolder Healthcare Solutions
Top Indian Pharma formulators eyeing OTC market: Report
NABL working towards calibration of medical equipments
WHO recommends testing before use of Sanofi's dengue vaccine
Fortis Update: Munjals, Burmans better their offer, BLK promoter likely to bid
Lupin gets tentative USFDA nod to market testosterone gel
Doctors, medical professionals highest paid in India: Report
Another Suitor in Line for Fortis, this time a Chinese Conglomerate
Maximum 24 percent Margin on Scheduled drugs, 30 on Non scheduled: NITI Aayog
Govt to define stem cells as DRUG, regulate use in therapy
Mosquitoes, gnats in Plant; no quality control: USFDA investigators Observe on Alkem Plant
Prev
Next
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our
Cookie Policy
and
Cookie Settings.
Ok